Product Overview
Retatrutide Triple GIP/GLP-1/Glucagon Receptor Agonist Peptide
High-quality Retatrutide for triple receptor agonists and laboratory analytical research
Retatrutide is supplied as a triple gip/glp-1/glucagon receptor agonist peptide for qualified laboratory research. It is intended for laboratory studies of GIP, GLP-1 and glucagon receptor signalling, triple-receptor pharmacology, peptide characterisation and metabolic pathway research. Available specifications: 5 mg, 10 mg, 15 mg, 20 mg, 22 mg, 24 mg, 30 mg, 36 mg, 40 mg, 50 mg, 60 mg; 10 vials per box. The featured SKU contains 30 mg in a 3 mL vial, packed 10 vials per box, with a minimum order of 100 boxes (1,000 vials). For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Synonym(s): Retatrutide; LY3437943
Packaging & Availability
Pricing is supplied on request. Select one or more pack sizes to add them to your quote cart.
| Select | SKU | Pack Size | Availability | Price |
|---|---|---|---|---|
| RT5 | 5mg/vial | 10vial/box;MOQ:100boxes or 1000vial | On request | |
| RT10 | 10mg/vial | 10vial/box;MOQ:100boxes or 1000vial | On request | |
| RT15 | 15mg/vial | 10vial/box;MOQ:100boxes or 1000vial | On request | |
| RT20 | 20mg/vial | 10vial/box;MOQ:100boxes or 1000vial | On request | |
| RT30 | 30mg/vial | 10vial/box;MOQ:100boxes or 1000vial | On request | |
| RT40 | 40mg/vial | 10vial/box;MOQ:100boxes or 1000vial | On request | |
| RT50 | 50mg/vial | 10vial/box;MOQ:100boxes or 1000vial | On request | |
| RT60 | 60mg/vial | 10vial/box;MOQ:100boxes or 1000vial | On request |
Product Overview
Retatrutide is a modified peptide used in laboratory studies of GIP, GLP-1 and glucagon receptor signalling, triple-receptor pharmacology, peptide characterisation and metabolic pathway research. The material is intended for qualified research organisations, analytical laboratories and product-development teams. It is supplied under batch-controlled conditions, and the final website specification must match the released COA.
Key Features
- Product type: Triple GIP/GLP-1/Glucagon Receptor Agonist Peptide
- Featured specification: 30 mg / 3 mL per vial; 10 vials per box
- Purity / grade: ≥99% by HPLC, subject to the batch COA
- Appearance: White to off-white lyophilized powder; confirm against the batch COA
- Documentation: Batch COA; HPLC chromatogram; MS report; SDS and specification sheet where applicable
- Bulk supply and custom labelling are available subject to technical and compliance review
- Minimum order: 100 boxes (1,000 vials)
Research Applications
Typical non-clinical research use includes triple receptor agonists, receptor or enzyme assays, peptide or small-molecule characterisation, chromatographic method development, mass-spectrometric confirmation, stability assessment and formulation compatibility studies. Researchers should determine suitability for their own protocol.
Supply & Quality Documentation
Batch-specific quality documentation is available according to the selected grade and order. Technical values shown on the website should be reconciled with the final COA, HPLC and MS results before release. For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Frequently Asked Questions
What is Retatrutide?
Retatrutide is a modified peptide used in laboratory studies of GIP, GLP-1 and glucagon receptor signalling, triple-receptor pharmacology, peptide characterisation and metabolic pathway research. It is supplied solely for qualified laboratory research.
What specifications are available for Retatrutide?
Current catalogue specifications are 5 mg, 10 mg, 15 mg, 20 mg, 22 mg, 24 mg, 30 mg, 36 mg, 40 mg, 50 mg, 60 mg; 10 vials per box. Final availability must be confirmed when requesting a quotation.
What purity is supplied?
≥99% by HPLC, subject to the batch COA. The batch COA is the controlling quality record.
Which quality documents are available?
Batch COA; HPLC chromatogram; MS report; SDS and specification sheet where applicable. Document availability depends on the selected grade and batch.
How should Retatrutide be stored?
Store sealed at −20°C, protected from light and moisture. After reconstitution, follow the batch-specific stability instructions and avoid repeated freeze–thaw cycles.
Is Retatrutide intended for human use?
No. It is supplied for laboratory research only and is not intended for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
Product Properties
Product Information
- Product Name: Retatrutide
- Synonym: LY3437943
- Product Type: Research Peptide
- Appearance: White to Off-White Lyophilized Powder
- Purity: ≥99% (HPLC)
- Specification: 30 mg / 3 mL
- Packaging: 10 Vials / Box
- Minimum Order Quantity: 100 Boxes (1000 Vials)
Quality Assurance
Every production batch is manufactured under strict quality management procedures.
Available quality documents include:
- Certificate of Analysis (COA)
- HPLC Purity Report
- Mass Spectrometry (MS) Report
- Product Specification Sheet
Additional technical documentation is available upon request.
Storage Conditions
Store unopened vials at −20°C in a dry environment away from direct sunlight.
Avoid repeated freeze-thaw cycles after reconstitution.
Packaging & Supply
Standard Packaging
- 30 mg / Vial
- 3 mL Sterile Glass Vial
- 10 Vials / Box
Bulk packaging and OEM labeling services are available according to customer requirements.
Applications
Suitable for laboratory research including:
- Peptide Research
- Analytical Method Development
- Pharmaceutical Research
- Biochemical Research
- Protein & Peptide Studies
For laboratory research use only. Not intended for human consumption or clinical applications.
For laboratory research use only. Not for human consumption, clinical use, diagnosis, treatment, compounding or veterinary use.
- Read the batch-specific Safety Data Sheet before handling.
- Use suitable laboratory gloves, protective clothing and eye protection.
- Avoid inhalation, ingestion and direct contact with skin or eyes.
- Use only in a controlled laboratory environment with appropriate engineering controls.
- Store sealed at −20°C, protected from light and moisture. After reconstitution, follow the batch-specific stability instructions and avoid repeated freeze–thaw cycles.
- Dispose of unused material, containers and solutions in accordance with institutional and local regulations.
No clinical dosing, treatment or consumer-use information is provided.
Quality & Documentation
Safety Data Sheet (SDS), Certificate of Analysis (COA) and specification documents can be supplied with your quotation.